PATENT CLAIM ANALYSIS

Application Number: 15761861
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-08
Patent Classification: ["514", "229800"]

Abstract:
Disclosed are a quinoline derivative, and a pharmaceutical composition, a preparation method and a use thereof. The quinoline derivative of the present invention has a c-Met inhibitory activity and can be used for the treatment, relieving and/or prevention of cancers or similar diseases.

Claim (Index 7):
A preparation method for the quinoline derivative, the tautomer, the mesomer, the racemate, the enantiomer, the diastereomer, or the pharmaceutically acceptable salt thereof according to  claim 1 , which is selected from\n method 1, when Z is \u2014CR a R b , the method comprises: method 2, when Z is S, the method comprises:

Metadata:
- Claim Count in Document: 20.0
- Percentile: 93.0
- Lexical Diversity: 1.37143
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15736898', '15030125', '14365497', '15766985', '14889092']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8192231213993888
- 35 USC 102 Novelty (BERT): 0.5293433227168237
- Combined Prediction Score: 0.7902351415311324
- Mean Citation Score: 338.76736
- Max Citation Score: 352.5189
- Similarity Product: 269.84290436775683

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test